Around the Watercooler

Key Stories from Around the Industry

Amgen restructures to focus resources on late-stage drugs
Posted: 10/20/2011

Will Emerging Markets Really Save Pharma?
Posted: 10/20/2011

Semprus wins $1 million Army grant to develop orthopedic devices
Posted: 10/20/2011

Playing Computer Games Helps Parkinson's Patients
Posted: 10/20/2011

Pressure Grows on Drugmakers to Reveal R&D Returns
Posted: 10/19/2011

Could Abbott Laboratories's Drug Biz Be a Potential $54 Billion Takeover Target?
Posted: 10/19/2011

FDA, Gilead And HIV Prevention-In-A-Pill?
Posted: 10/19/2011

Abbott Labs to split into two public companies
Posted: 10/19/2011

Par Pharma suit could set up off-label court showdown
Posted: 10/18/2011

InvaGen, Inc. Looks to Expand in New York; Will Create and Retain Nearly 700 Jobs
Posted: 10/18/2011

Edwards loses nearly 5 percent on FDA rumor
Posted: 10/18/2011

World's first malaria vaccine works in major trial
Posted: 10/18/2011

Ben Franklin Technology awards $400K to early-stage device firms
Posted: 10/18/2011

Sequenom Inc. Inaugurates New Diagnostic Test for Down Syndrome
Posted: 10/17/2011

Beaker's Blog

Great idea + lots of bureaucracy = National Bioeconomy Blueprint
Posted: 10/20/2011

Undiversified: Will the real Abbott Labs please stand up
Posted: 10/20/2011

Cool technology: The Berlin Heart
Posted: 10/20/2011

Forget Wall Street: Pfizer hit by Occupy Big Pharma?
Posted: 10/18/2011

FDA Commish on budget, regulatory process
Posted: 10/18/2011

BIO speaks out on path forward for FDA
Posted: 10/17/2011